COI
VIVO

Connable Office Inc’s Meridian Bioscience Inc VIVO Stock Holding History

Connable Office Inc’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-12,583
Closed -$383K – 220
2022
Q2 		$383K Hold
12,583
– – 0.06% 132
2022
Q1 		$327K Buy
+12,583
New +$299K 0.04% 173
2021
Q4 		– Sell
-11,496
Closed -$221K – 233
2021
Q3 		$221K Hold
11,496
– – 0.03% 201
2021
Q2 		$255K Sell
11,496
-4,653
-29% -$98.7K 0.04% 189
2021
Q1 		$424K Buy
+16,149
New +$384K 0.06% 150

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Connable Office Inc's VIVO Position: Q3 2022 in Review

Connable Office Inc sold out of Meridian Bioscience Inc (VIVO) in Q3 2022, closing a stake of 12,583 shares — an estimated $383K sold.

Connable Office Inc first reported a position in VIVO in Q1 2021 and held it in 5 quarters. The position peaked at $424K in Q1 2021. 203 funds tracked by Wall St. Rank hold VIVO as of Q3 2022.

  • Connable Office Inc reported no remaining Meridian Bioscience Inc position as of Q3 2022 after selling out during the quarter.
  • Connable Office Inc sold 12,583 Meridian Bioscience Inc shares in Q3 2022, an estimated $383K.
  • Connable Office Inc first reported a position in Meridian Bioscience Inc in Q1 2021 and held it in 5 quarters.
  • Connable Office Inc's Meridian Bioscience Inc position peaked at $424K in Q1 2021.
  • 203 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2022.

Based on Connable Office Inc's 13F filing for Q3 2022, filed 26 Oct 2022.